ARIXTRA Local Study For Registration In China.
NCT00328939 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 240
Last updated 2012-06-04
Summary
This is a local registration study in China to compare the safety and efficacy of ARIXTRA to Enoxaparine in patients undergoing elective major hip or knee replacement or a revision of components.
Conditions
- Thromboembolism
- Knee Replacement
- Hip Replacement
Interventions
- DRUG
-
ARIXTRA infusion
- DRUG
-
Enoxaparine infusion
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
GSK Clinical Trials · GlaxoSmithKline
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-05-31
Countries
- China
Study Locations
More Related Trials
-
Evaluation Of Fondaparinux (Also Called ARIXTRA) 2.5 mg Subcutaneously Once Daily For The Treatment Of Superficial Thrombophlebitis (Also Known As Superficial Vein Thrombosis)
NCT00443053 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of JNJ-70033093 (BMS-986177) Versus Subcutaneous Enoxaparin in Participants Undergoing Elective Total Knee Replacement Surgery
NCT03891524 ·Status: COMPLETED ·Phase: PHASE2
-
Dose Ranging Study in Elective Total Hip Replacement Surgery
NCT00338897 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Healthy Volunteer PK/PD, Safety and Tolerability Study of Second Generation Andexanet Alfa
NCT03083704 ·Status: COMPLETED ·Phase: PHASE1
-
Enoxaparin for Preventing the Radical Artery Occlusion After the Transradial Access Hepatic Arterial Infusion Chemotherapy
NCT06293287 ·Status: RECRUITING ·Phase: PHASE2
-
A Study to Evaluate the Safety and Efficacy of Intravenous JNJ-64179375 Versus Oral Apixaban in Participants Undergoing Elective Total Knee Replacement Surgery
NCT03251482 ·Status: COMPLETED ·Phase: PHASE2
-
Total Hip Replacement Study With XRP4563 (Enoxaparin Sodium)
NCT00349180 ·Status: COMPLETED ·Phase: PHASE3
-
Dose-confirmatory Bridging Study in Total Hip Replacement
NCT01205932 ·Status: COMPLETED ·Phase: PHASE3
-
Dose-confirmatory Bridging Study in Total Knee Replacement
NCT01206972 ·Status: COMPLETED ·Phase: PHASE3
-
Prevention of Thromboembolic Events in Total Knee Replacement Patients
NCT03393481 ·Status: WITHDRAWN ·Phase: PHASE2
-
Phase IIa Venous Thromboembolism (VTE) Prevention Study In Total Knee Replacement (TKR)
NCT00541320 ·Status: WITHDRAWN ·Phase: PHASE2
-
Special Drug Use Investigation for Arixtra® (Fondaparinux) Venous Thromboembolism Treatment
NCT01428531 ·Status: COMPLETED
-
Safety and Efficacy of TeaRx Xa Factor Direct Inhibitor Versus Enoxaparin as a Venous Thromboembolic Events (VTE) Prevention Following Total Knee Replacement
NCT03088358 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Apixaban for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery
NCT00371683 ·Status: COMPLETED ·Phase: PHASE3
-
Factor XI inhibiTion for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty
NCT06180889 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Enoxaparin 20mg Versus 30mg Subcutaneously Once Daily in Elderly Patients With Impaired Renal Function
NCT03158792 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Observe Safety of Xarelto in VTE Prophlylaxis After Elective TKR (Total Knee Replacement) or THR (Total Hip Replacement)
NCT01523418 ·Status: WITHDRAWN
-
Pilot Study Evaluating Alterations in Thrombogenicity and Platelet Reactivity Following Lower Extremity Arthroplasty
NCT01809054 ·Status: COMPLETED ·Phase: PHASE4
-
Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement Surgery
NCT00331838 ·Status: COMPLETED ·Phase: PHASE2
-
BIBR 1048 Dose Range Finding Study in Prevention of Venous Thromboembolism in Patients With Primary Elective Total Hip or Knee Replacement Surgery
NCT01225822 ·Status: COMPLETED ·Phase: PHASE2
-
Hemorrhage Risk Prescribed Arixtra
NCT01064362 ·Status: COMPLETED
-
The Effect of Prophylactic Anticoagulation on Major Bleeding Events in Hospitalized Chronic Kidney Disease and Lower Limb Fracture Patients.
NCT06795698 ·Status: COMPLETED ·Phase: PHASE2
-
Xarelto for Thromboprophylaxis After Total Hip and Total Knee Arthroplasty
NCT05449327 ·Status: COMPLETED ·Phase: NA
-
Comparison of Arixtra vs. Lovenox to Prevent Blood Clots in Medically Ill Patients
NCT00521885 ·Status: TERMINATED ·Phase: NA
-
Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery
NCT00452530 ·Status: COMPLETED ·Phase: PHASE3